US Stock MarketDetailed Quotes

Pliant Therapeutics (PLRX)

Watchlist
  • 1.170
  • -0.010-0.85%
Close May 13 16:00 ET
  • 1.170
  • 0.0000.00%
Post 16:10 ET
72.45MMarket Cap-0.64P/E (TTM)

Pliant Therapeutics (PLRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-63.06%21.77M
-31.52%156.37M
-55.78%23.58M
-54.42%28.27M
-24.81%45.59M
12.49%58.94M
22.96%228.37M
13.36%53.32M
30.05%62.01M
27.46%60.64M
Selling and administrative expenses
-47.17%8.19M
-20.05%47.22M
-44.99%7.99M
-27.55%10.33M
-10.84%13.39M
1.66%15.5M
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
-General and administrative expense
-47.17%8.19M
-20.05%47.22M
-44.99%7.99M
-27.55%10.33M
-10.84%13.39M
1.66%15.5M
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
Research and development costs
-68.73%13.58M
-35.53%109.16M
-59.83%15.59M
-62.44%17.94M
-29.42%32.2M
16.93%43.44M
32.48%169.31M
16.91%38.79M
47.67%47.75M
38.22%45.62M
Operating profit
63.06%-21.77M
31.52%-156.37M
55.78%-23.58M
54.42%-28.27M
24.81%-45.59M
-12.49%-58.94M
-24.01%-228.37M
-13.36%-53.32M
-30.05%-62.01M
-28.13%-60.64M
Net non-operating interest income expense
-37.45%1.73M
-50.96%8.86M
-49.05%1.83M
-53.71%1.97M
-52.10%2.29M
-49.07%2.77M
-20.82%18.06M
-39.47%3.59M
-31.41%4.25M
-22.02%4.79M
Non-operating interest income
-51.46%1.73M
-45.86%11.42M
-55.59%1.96M
-45.73%2.78M
-45.14%3.1M
-39.34%3.57M
-12.42%21.09M
-29.24%4.42M
-21.29%5.13M
-12.42%5.65M
Non-operating interest expense
--0
-15.38%2.56M
-83.69%136K
-7.07%815K
-6.80%809K
79.55%799K
138.67%3.02M
159.81%834K
176.66%877K
172.10%868K
Other net income (expense)
-1.83M
Special income (charges)
----
---1.83M
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
--1.83M
----
----
----
----
----
----
----
----
Income before tax
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Income tax
Net income
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Net income continuous Operations
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Minority interest income
Net income attributable to the parent company
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
64.32%-20.04M
28.99%-149.34M
52.59%-23.58M
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
Basic earnings per share
65.22%-0.32
29.97%-2.43
53.66%-0.38
54.74%-0.43
22.83%-0.71
-17.95%-0.92
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
Diluted earnings per share
65.22%-0.32
29.97%-2.43
53.66%-0.38
54.74%-0.43
22.83%-0.71
-17.95%-0.92
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -63.06%21.77M-31.52%156.37M-55.78%23.58M-54.42%28.27M-24.81%45.59M12.49%58.94M22.96%228.37M13.36%53.32M30.05%62.01M27.46%60.64M
Selling and administrative expenses -47.17%8.19M-20.05%47.22M-44.99%7.99M-27.55%10.33M-10.84%13.39M1.66%15.5M1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M
-General and administrative expense -47.17%8.19M-20.05%47.22M-44.99%7.99M-27.55%10.33M-10.84%13.39M1.66%15.5M1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M
Research and development costs -68.73%13.58M-35.53%109.16M-59.83%15.59M-62.44%17.94M-29.42%32.2M16.93%43.44M32.48%169.31M16.91%38.79M47.67%47.75M38.22%45.62M
Operating profit 63.06%-21.77M31.52%-156.37M55.78%-23.58M54.42%-28.27M24.81%-45.59M-12.49%-58.94M-24.01%-228.37M-13.36%-53.32M-30.05%-62.01M-28.13%-60.64M
Net non-operating interest income expense -37.45%1.73M-50.96%8.86M-49.05%1.83M-53.71%1.97M-52.10%2.29M-49.07%2.77M-20.82%18.06M-39.47%3.59M-31.41%4.25M-22.02%4.79M
Non-operating interest income -51.46%1.73M-45.86%11.42M-55.59%1.96M-45.73%2.78M-45.14%3.1M-39.34%3.57M-12.42%21.09M-29.24%4.42M-21.29%5.13M-12.42%5.65M
Non-operating interest expense --0-15.38%2.56M-83.69%136K-7.07%815K-6.80%809K79.55%799K138.67%3.02M159.81%834K176.66%877K172.10%868K
Other net income (expense) -1.83M
Special income (charges) -------1.83M------------------0------------
-Less:Other special charges ------1.83M--------------------------------
Income before tax 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Income tax
Net income 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Net income continuous Operations 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Minority interest income
Net income attributable to the parent company 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 64.32%-20.04M28.99%-149.34M52.59%-23.58M54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M
Basic earnings per share 65.22%-0.3229.97%-2.4353.66%-0.3854.74%-0.4322.83%-0.71-17.95%-0.92-26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92
Diluted earnings per share 65.22%-0.3229.97%-2.4353.66%-0.3854.74%-0.4322.83%-0.71-17.95%-0.92-26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More